Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.

Insulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major pathophysiological defect of type 2 diabetes mellitus. Although IR is closely associated with obesity, the identity of the molecular defect(s) underlying obesity-induced IR in skeletal muscle remains...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio J Ruiz-Alcaraz, Christopher Lipina, John R Petrie, Michael J Murphy, Andrew D Morris, Calum Sutherland, Daniel J Cuthbertson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056928&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434162744786944
author Antonio J Ruiz-Alcaraz
Christopher Lipina
John R Petrie
Michael J Murphy
Andrew D Morris
Calum Sutherland
Daniel J Cuthbertson
author_facet Antonio J Ruiz-Alcaraz
Christopher Lipina
John R Petrie
Michael J Murphy
Andrew D Morris
Calum Sutherland
Daniel J Cuthbertson
author_sort Antonio J Ruiz-Alcaraz
collection DOAJ
description Insulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major pathophysiological defect of type 2 diabetes mellitus. Although IR is closely associated with obesity, the identity of the molecular defect(s) underlying obesity-induced IR in skeletal muscle remains controversial; reduced post-receptor signalling of the insulin receptor substrate 1 (IRS1) adaptor protein and downstream effectors such as protein kinase B (PKB) have previously been implicated. We examined expression and/or activation of a number of components of the insulin-signalling cascade in skeletal muscle of 22 healthy young men (with body mass index (BMI) range, 20-37 kg/m(2)). Whole body insulin sensitivity (M value) and body composition was determined by the hyperinsulinaemic (40 mU. min(-1).m(-2).), euglycaemic clamp and by dual energy X-ray absorptiometry (DEXA) respectively. Skeletal muscle (vastus lateralis) biopsies were taken before and after one hour of hyperinsulinaemia and the muscle insulin signalling proteins examined by western blot and immunoprecipitation assay. There was a strong inverse relationship between M-value and BMI. The most striking abnormality was significantly reduced insulin-induced activation of p42/44 MAP kinase, measured by specific assay, in the volunteers with poor insulin sensitivity. However, there was no relationship between individuals' BMI or M-value and protein expression/phosphorylation of IRS1, PKB, or p42/44 MAP kinase protein, under basal or hyperinsulinaemic conditions. In the few individuals with poor insulin sensitivity but preserved p42/44 MAP kinase activation, other signalling defects were evident. These findings implicate defective p42/44 MAP kinase signalling as a potential contributor to obesity-related IR in a non-diabetic population, although clearly multiple signalling defects underlie obesity associated IR.
format Article
id doaj-art-dbbdf793106c47e1a744e9a25b32b590
institution Kabale University
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-dbbdf793106c47e1a744e9a25b32b5902025-08-20T03:26:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5692810.1371/journal.pone.0056928Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.Antonio J Ruiz-AlcarazChristopher LipinaJohn R PetrieMichael J MurphyAndrew D MorrisCalum SutherlandDaniel J CuthbertsonInsulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major pathophysiological defect of type 2 diabetes mellitus. Although IR is closely associated with obesity, the identity of the molecular defect(s) underlying obesity-induced IR in skeletal muscle remains controversial; reduced post-receptor signalling of the insulin receptor substrate 1 (IRS1) adaptor protein and downstream effectors such as protein kinase B (PKB) have previously been implicated. We examined expression and/or activation of a number of components of the insulin-signalling cascade in skeletal muscle of 22 healthy young men (with body mass index (BMI) range, 20-37 kg/m(2)). Whole body insulin sensitivity (M value) and body composition was determined by the hyperinsulinaemic (40 mU. min(-1).m(-2).), euglycaemic clamp and by dual energy X-ray absorptiometry (DEXA) respectively. Skeletal muscle (vastus lateralis) biopsies were taken before and after one hour of hyperinsulinaemia and the muscle insulin signalling proteins examined by western blot and immunoprecipitation assay. There was a strong inverse relationship between M-value and BMI. The most striking abnormality was significantly reduced insulin-induced activation of p42/44 MAP kinase, measured by specific assay, in the volunteers with poor insulin sensitivity. However, there was no relationship between individuals' BMI or M-value and protein expression/phosphorylation of IRS1, PKB, or p42/44 MAP kinase protein, under basal or hyperinsulinaemic conditions. In the few individuals with poor insulin sensitivity but preserved p42/44 MAP kinase activation, other signalling defects were evident. These findings implicate defective p42/44 MAP kinase signalling as a potential contributor to obesity-related IR in a non-diabetic population, although clearly multiple signalling defects underlie obesity associated IR.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056928&type=printable
spellingShingle Antonio J Ruiz-Alcaraz
Christopher Lipina
John R Petrie
Michael J Murphy
Andrew D Morris
Calum Sutherland
Daniel J Cuthbertson
Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.
PLoS ONE
title Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.
title_full Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.
title_fullStr Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.
title_full_unstemmed Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.
title_short Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.
title_sort obesity induced insulin resistance in human skeletal muscle is characterised by defective activation of p42 p44 map kinase
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056928&type=printable
work_keys_str_mv AT antoniojruizalcaraz obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase
AT christopherlipina obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase
AT johnrpetrie obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase
AT michaeljmurphy obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase
AT andrewdmorris obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase
AT calumsutherland obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase
AT danieljcuthbertson obesityinducedinsulinresistanceinhumanskeletalmuscleischaracterisedbydefectiveactivationofp42p44mapkinase